Novel water-based preparation formulation of methylamino abamectin benzoate

A technology of methylamino abamectin and benzoate, applied in the directions of insecticides, biocides, animal repellents, etc., can solve the problem of no delayed effect, volatilization and loss of active ingredients, and insufficient rapid effect of harmful organisms and other problems, to increase the utilization rate, increase the content of active ingredients, and achieve the effects of contact killing and stomach poisoning.

Inactive Publication Date: 2014-02-12
GUANGDONG ZHONGXUN AGRI TECH
View PDF10 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The deficiencies of the existing microcapsule suspension: because the active ingredient is microencapsulated, the active ingredient is wrapped in the polymer capsule wall material, so the active ingredient has a good effect in the state of controlled release. slow-acting, but not quick-acting to harmful organisms, not very good knockdown or quick-acting
However, the common water-emulsion water-emulsion, because the active ingredient is in the form of liquid particles, is easily affected by environmental factors (such as: temperature, wind) on the leaves after spraying, causing the volatilization and loss of active ingredients, so it does not have a good delayed effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel water-based preparation formulation of methylamino abamectin benzoate
  • Novel water-based preparation formulation of methylamino abamectin benzoate
  • Novel water-based preparation formulation of methylamino abamectin benzoate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The processing method of emamectin benzoate new dosage form ZW in the present embodiment is as follows: first adopt interfacial polymerization method to process 1% emamectin benzoate microcapsule suspension, conventional method processes 1% Emamectin benzoate emulsion in water, the two are evenly mixed according to the mass ratio of 7:3 to obtain 1% emamectin benzoate ZW.

[0032]Table 1, interfacial polymerization method processing emamectin benzoate microcapsule suspension and the formula of conventional method processing water emulsion.

[0033]

[0034] The prepared 1% emamectin benzoate new dosage form ZW can meet the following technical indicators: suspension rate ≥ 93%; emulsion stability qualified; cyst formation rate ≥ 91%; automatic dispersibility ≥ 90%; The pH value is qualified; all indexes of cold storage are qualified; all indexes of hot storage are qualified; all indexes of freeze-thaw stability are qualified.

Embodiment 2

[0036] The processing method of emamectin benzoate new dosage form ZW in the present embodiment is as follows: first adopt interface polymerization method to process 2% emamectin benzoate microcapsule suspension concentrate, conventional method processes 2% Emamectin benzoate emulsion in water, the two are evenly mixed according to the mass ratio of 7:3 to obtain 2% emamectin benzoate ZW.

[0037] Table 2, interfacial polymerization method processing emamectin benzoate microcapsule suspension and the formula of conventional method processing water emulsion.

[0038]

[0039] The prepared 2% emamectin benzoate new dosage form ZW can meet the following technical indicators: suspension rate ≥ 93%; emulsion stability qualified; cyst formation rate ≥ 91%; automatic dispersibility ≥ 90%; The pH value is qualified; all indexes of cold storage are qualified; all indexes of hot storage are qualified; all indexes of freeze-thaw stability are qualified.

Embodiment 3

[0041] In the present embodiment, the processing method of emamectin benzoate new dosage form ZW is as follows: firstly adopt the interfacial polymerization method to process 4% emamectin benzoate microcapsule suspension, and conventional method processes 4% Emamectin benzoate emulsion in water, the two are evenly mixed according to the mass ratio of 7:3 to obtain 4% emamectin benzoate ZW.

[0042] Table 3, interfacial polymerization processing emamectin benzoate microcapsule suspension and conventional method processing water emulsion mixed.

[0043]

[0044]

[0045] The prepared 4% emamectin benzoate new dosage form ZW can meet the following technical indicators: suspension rate ≥ 93%; emulsion stability qualified; cyst formation rate ≥ 91%; automatic dispersibility ≥ 90%; The pH value is qualified; all indexes of cold storage are qualified; all indexes of hot storage are qualified; all indexes of freeze-thaw stability are qualified.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel water-based preparation formulation of methylamino abamectin benzoate, which is a microcapsule suspending agent-aqueous emulsion formed by mixing a methylamino abamectin benzoate microcapsule suspending agent and a methylamino abamectin benzoate aqueous emulsion. The preparation formulation is composed of the following components in percentage by mass: 0.5-6% of methylamino abamectin benzoate, 1-15% of solvent, 1-20% of encapsulating agent, 1-10% of surfactant, 1-10% of antifreezing agent, 0.01-1% of thickener, 0.01-5% of pH regulator, 0.01-1% of defoaming agent, 0.01-1% of preservative and the balance of water. The preparation formulation can lower the consumption of the organic solvent and alleviate the environmental hazard, has the advantages of quick effect taking, high durability and stable performance, and is convenient to use.

Description

technical field [0001] The invention belongs to the technical field of pesticide production and processing, and in particular relates to a new water-based dosage form of emamectin benzoate. Background technique [0002] In 2010, the "China Pesticide Industry Policy" jointly issued by the Ministry of Industry and Information Technology, the Ministry of Environmental Protection, the Ministry of Agriculture, and the General Administration of Quality Supervision, Inspection and Quarantine clearly stipulated that "accelerate the research and development of high-safety, low-risk products and application technologies, and gradually restrict and eliminate high-toxicity and high-pollution , high environmental risk pesticide products and technology”, “vigorously promote the development of agricultural preparations in the direction of high efficiency and safety such as water-based, dust-free, and controlled release.” The R&D and production of the first generation of environmentally-fri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01N25/04A01N43/90A01P7/04
Inventor 袁彩宾孟宪秋曹希敏
Owner GUANGDONG ZHONGXUN AGRI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products